Explore Stanford technologies available for licensing:

Researchers at Stanford have developed Electro-LEV, a microfluidic platform that uses programmable electromagnets to levitate and sort cells by their physical properties — with no fluorescent labels or antibodies required.

Over 1.3 million hip and knee replacements are performed in the US annually.

Malignant tumor cells shed their DNA into the bloodstream of breast cancer patients in the form of cell-free DNA (cfDNA) and can be assayed to identify cancer-associated biomarkers.

Researchers at Stanford have developed Elastic Rod Origami (RodOri), a new class of mechanical structures that can be physically reconfigured into many different shapes, each with distinct and precisely controlled mechanical properties.

Stanford researchers have developed an innovative biomimetic cardiac sleeve designed to provide passive external mechanical support to the heart while mimicking the natural motion and mechanical behavior of healthy ventricular tissue.

Stanford scientists have developed a low-profile percutaneous gastrostomy tube that can be placed in a single endoscopic procedure, reducing tube dislodgement and patient discomfort.

Stanford researchers have developed a highly efficient, portable heater-cooler unit (HCU) designed for normothermia management in patients on mechanical circulatory support (MCS), addressing critical limitations of current systems.

The TGF-beta signaling pathway is a key regulator of many biological processes and is involved in the pathogenesis of major diseases. Regulating this pathway could have broad application to treating neurodegenerative diseases, stroke, tumors, wound healing etc.

Prof. Tony Wyss-Coray and colleagues have identified a first-in-class small molecule with the potential for treating Alzheimer's disease and reversing some of its pathology.

Researchers at Stanford have developed a method to tag and identify disease associated proteins for the development of prognostic or diagnostic biomarkers. Biomarker discovery is foundational to the effective treatment and management of numerous diseases.

Researchers at Stanford University have developed a new stimulation algorithm for implantable brain stimulation devices that more reliably treats neurological disorders driven by abnormal synchronized brain activity.

Stanford researchers have found a cell-free biomanufacturing process that can make valuable chemicals more efficiently than traditional fermentation.

Pelvic organ prolapse affects 3-6% of US women, with 50% lifetime risk, especially following vaginal childbirth.

Stanford researchers have developed an innovative, mechanically tunable microneedle applicator that enables consistent and reliable insertion of microneedle arrays into skin for drug delivery, diagnostics, and sampling applications.

Stanford researchers have developed an innovative vacuum-integrated microneedle platform designed to enable efficient and reliable collection of dermal interstitial fluid (ISF) for diagnostic and biomarker analysis.